Aa
Aa
A
A
A
Close
4113881 tn?1415850276

Interferon-Free Regimens in Development for HCV Genotypes 2, 3, & 4

Interferon-Free Regimens in Development for HCV Genotypes 2, 3, & 4

Regimen                                              Status/Sponsor                    Population                                    Duration

ABT-267 + ABT-450/r +/− RBV           Phase IIAbbVie       Treatment-naive;HCV genotypes 2 & 3    Not Specified

FDC: ABT-267/ABT-450/r + ABT-333 + RBV        Phase IIAbbVie Treatment-naive and treatment-experienced (no prior DAA)                                                                                                                                             12 weeks

asunaprevir + daclatasvir + BMS-791325          Phase II BMS    Treatment-naive;HCV genotype 4    12 or 24 weeks

daclatasvir + sofosbuvir+/− RBV   Phase IIBMS/Pharmasset  Treatment-naive;non-cirrhotic;HCV genotypes 2 & 3
                                                                                                                                                             24 weeks

sofosbuvir + GS-5816     Phase II  Gilead Treatment-naive, non-cirrhotic; HCV genotypes 2, 3, 4, 5, & 6   12 weeks

FDC: sofosbuvir/ledipasvir or sofosbuvir + GS-9669 Phase II Gilead Treatment-naive or null responders (no prior DAA); HCV genotype 4                                                                                                                         12 weeks

FDC: sofosbuvir/ledipasvir +/− RBV Phase II GileadTreatment-naive; HCV genotype 3              12 weeks

sofosbuvir + RBV Phase II  Gilead Interferon-ineligible or-intolerant; HCV genotypes 2 & 3         12 weeks

sofosbuvir + RBV Phase II Gilead All genotypes; no prior treatment with HCV nucleoside/tide; portal hypertension with or without hepatic decompensation                                                                                         48 weeks Posttransplant 24 weeks Pretransplant (for hepatocellular carcinoma) 24 weeks

sofosbuvir + RBV Phase II Gilead Treatment-naive and treatment-experienced Egyptian adults; HCV genotype 4 12 or 24 weeks

sofosbuvir + RBV Phase III Gilead Prior sofosbuvir study participants; HCV genotypes 2 & 3 12 weeks Treatment-naive; interferon- intolerant, -ineligible, or -unwilling 12 weeks Treatment-experienced (no prior DAA); HCV genotypes 2 & 3 12 or 16 weeks
2 Responses
Sort by: Helpful Oldest Newest
Avatar universal
Good of you to share this.  
Helpful - 0
4113881 tn?1415850276
well, it doesnt look so pretty. I tried. Heres the link.

http://www.pipelinereport.org/2013/hcv
Helpful - 0
You must join this user group in order to participate in this discussion.

You are reading content posted in the Hep C Gt3 Group

Didn't find the answer you were looking for?
Ask a question
Popular Resources
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.